2023 Q4 Form 10-Q Financial Statement

#000147793223008665 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Gross Profit $0.00 $0.00 $0.00
YoY Change -100.0%
Gross Profit Margin
Selling, General & Admin $45.70K $70.00K $153.5K
YoY Change -54.38% 192.96%
% of Gross Profit
Research & Development $2.000K $5.463K $0.00
YoY Change -97.14%
% of Gross Profit
Depreciation & Amortization $270.6K $10.00K $20.81K
YoY Change 2606.4% -51.94% -31.15%
% of Gross Profit
Operating Expenses $312.1K $84.65K $174.3K
YoY Change 290.11% -51.42% 110.97%
Operating Profit -$312.1K -$84.65K -$174.3K
YoY Change 290.11% -51.42% 109.07%
Interest Expense -$55.64K -$640.0K -$71.70K
YoY Change -94.55% 792.61% -94.61%
% of Operating Profit
Other Income/Expense, Net -$62.04K -$635.2K -$74.70K
YoY Change 750.4% -105.61%
Pretax Income -$711.1K -$720.0K -$249.0K
YoY Change -35.36% 189.2% -82.4%
Income Tax
% Of Pretax Income
Net Earnings -$711.1K -$719.9K -$249.0K
YoY Change -35.36% 189.16% -82.4%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00 -$164.70
COMMON SHARES
Basic Shares Outstanding 1.978B shares 1.978B shares 1.505B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00 $1.000K
YoY Change -100.0%
Cash & Equivalents $0.00 $563.00 $1.000K
Short-Term Investments
Other Short-Term Assets $625.0K $450.0K $625.0K
YoY Change -0.79% -28.0%
Inventory
Prepaid Expenses
Receivables $0.00
Other Receivables
Total Short-Term Assets $625.0K $450.6K $626.0K
YoY Change 0.0% -28.03% 929.27%
LONG-TERM ASSETS
Property, Plant & Equipment $21.72K $34.85K $79.32K
YoY Change -68.15% -56.07% -36.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.793M $50.44K $98.13K
YoY Change 5429.65% -48.6% -51.75%
TOTAL ASSETS
Total Short-Term Assets $625.0K $450.6K $626.0K
Total Long-Term Assets $4.793M $50.44K $98.13K
Total Assets $5.418M $501.0K $724.1K
YoY Change 661.3% -30.81% 174.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $316.9K $220.0K $237.1K
YoY Change 37.77% -7.23% -12.97%
Accrued Expenses $501.3K $500.0K $501.3K
YoY Change 0.25% -0.25% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $2.612M $2.580M $2.474M
YoY Change 4.47% 4.29% 55.91%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.624M $5.591M $4.180M
YoY Change 7.56% 33.76% -6.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.624M $5.591M $4.180M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $5.624M $5.590M $4.180M
YoY Change 7.53% 33.74% -6.6%
SHAREHOLDERS EQUITY
Retained Earnings -$38.04M -$37.33M -$35.28M
YoY Change 4.56% 5.8%
Common Stock $2.024M $1.876M $1.534M
YoY Change 29.99% 22.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$205.5K -$5.090M -$3.456M
YoY Change
Total Liabilities & Shareholders Equity $5.418M $501.0K $724.1K
YoY Change 661.3% -30.81% 174.1%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$711.1K -$719.9K -$249.0K
YoY Change -35.36% 189.16% -82.4%
Depreciation, Depletion And Amortization $270.6K $10.00K $20.81K
YoY Change 2606.4% -51.94% -31.15%
Cash From Operating Activities $42.77K $70.00K -$460.0K
YoY Change -161.1% -115.22% -139490.91%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -42.77K -80.00K 435.4K
YoY Change -171.28% -118.38% -21441.67%
NET CHANGE
Cash From Operating Activities 42.77K 70.00K -460.0K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities -42.77K -80.00K 435.4K
Net Change In Cash 0.000 -10.00K -24.62K
YoY Change -100.0% -59.38% 1339.77%
FREE CASH FLOW
Cash From Operating Activities $42.77K $70.00K -$460.0K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow $42.77K $70.00K -$460.0K
YoY Change -161.1% -115.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001338929
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2500000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1557397662 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1875685127 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
600000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52047
dei Entity Registrant Name
EntityRegistrantName
AUTHENTIC HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
11-3746201
dei Entity Address Address Line1
EntityAddressAddressLine1
50 Division Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Somerset
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08873
dei City Area Code
CityAreaCode
732
dei Local Phone Number
LocalPhoneNumber
695-4389
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1978087926 shares
CY2023Q3 us-gaap Deposit Assets
DepositAssets
0 usd
CY2022Q4 us-gaap Deposit Assets
DepositAssets
0 usd
CY2023Q3 ahro Debt Discount On Convertible Debt
DebtDiscountOnConvertibleDebt
97000 usd
CY2022Q4 ahro Debt Discount On Convertible Debt
DebtDiscountOnConvertibleDebt
155641 usd
CY2023Q3 ahro Convertible Notes And Accrued Interest Related Party
ConvertibleNotesAndAccruedInterestRelatedParty
85568 usd
CY2022Q4 ahro Convertible Notes And Accrued Interest Related Party
ConvertibleNotesAndAccruedInterestRelatedParty
82568 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
40500 usd
CY2023Q3 ahro Note Payable Related Parties Classified Current
NotePayableRelatedPartiesClassifiedCurrent
505526 usd
CY2022Q4 ahro Note Payable Related Parties Classified Current
NotePayableRelatedPartiesClassifiedCurrent
495308 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
116978 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
169259 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
20806 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
79776 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
36475 usd
us-gaap Professional Fees
ProfessionalFees
87824 usd
CY2023Q3 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
0 usd
CY2022Q3 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
0 usd
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
0 usd
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
0 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
174259 usd
us-gaap Operating Expenses
OperatingExpenses
336859 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-174259 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-336859 usd
CY2022Q3 ahro Income Loss On Change In Fair Value Of Derivative Liabilities
IncomeLossOnChangeInFairValueOfDerivativeLiabilities
0 usd
ahro Income Loss On Change In Fair Value Of Derivative Liabilities
IncomeLossOnChangeInFairValueOfDerivativeLiabilities
478754 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Notes Receivable
GainLossOnSaleOfNotesReceivable
0 usd
us-gaap Gain Loss On Sale Of Notes Receivable
GainLossOnSaleOfNotesReceivable
15856 usd
ahro Income Loss On Joint Venture
IncomeLossOnJointVenture
-50000 usd
CY2022Q3 us-gaap Financing Interest Expense
FinancingInterestExpense
64267 usd
us-gaap Financing Interest Expense
FinancingInterestExpense
99369 usd
CY2022Q3 ahro Interest Expense Related Partie
InterestExpenseRelatedPartie
7433 usd
ahro Interest Expense Related Partie
InterestExpenseRelatedPartie
110267 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6750 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-74700 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
278224 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-248959 usd
us-gaap Profit Loss
ProfitLoss
-58635 usd
CY2022Q3 ahro Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.0002
ahro Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.0000
CY2022Q3 ahro Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
1511910607 shares
ahro Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
1534320739 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3679391 usd
CY2022Q1 ahro Conversion Of Notes Payable Amount
ConversionOfNotesPayableAmount
62407 usd
CY2022Q1 ahro Stock Warrants Issued For Cash
StockWarrantsIssuedForCash
60000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
391027 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-3165957 usd
CY2022Q2 ahro Stock Issued During Perod Value Conversion Of Notes
StockIssuedDuringPerodValueConversionOfNotes
100000 usd
CY2022Q2 ahro Stock Warrants Issued For Cash
StockWarrantsIssuedForCash
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-200703 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3266660 usd
CY2022Q3 ahro Issuance Of Common Stock Amount
IssuanceOfCommonStockAmount
60000 usd
CY2022Q3 ahro Stock Warrants Issued For Cash
StockWarrantsIssuedForCash
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-248959 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3455619 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4516802 usd
CY2023Q1 ahro Issuance Of Shares For Conversion Of Notes
IssuanceOfSharesForConversionOfNotes
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
35001 usd
CY2023Q1 ahro Adjustment Shares Issued Amount
AdjustmentSharesIssuedAmount
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1209261 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-5691062 usd
CY2023Q2 ahro Adjustment Shares Issued Amount
AdjustmentSharesIssuedAmount
0 usd
CY2023Q2 ahro Stock Issued During Perod Value Conversion Of Notes
StockIssuedDuringPerodValueConversionOfNotes
374694 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-981792 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4334639 usd
CY2023Q3 ahro Adjustment Shares Issued Amount
AdjustmentSharesIssuedAmount
-35107 usd
CY2023Q3 ahro Stock Warrants Issued For Cash
StockWarrantsIssuedForCash
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-719901 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5089647 usd
ahro Extinguishment Of Derivative Liabilities
ExtinguishmentOfDerivativeLiabilities
0 usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
46153 usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
60180 usd
ahro Increase Decrease In Bank Indebtedness
IncreaseDecreaseInBankIndebtedness
-306 usd
ahro Increase Decrease In Bank Indebtedness
IncreaseDecreaseInBankIndebtedness
-125 usd
us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0 usd
us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
127657 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
55221 usd
ahro Shares Issued For Convertible Notes Settlement
SharesIssuedForConvertibleNotesSettlement
0 usd
ahro Shares Issued For Convertible Notes Settlement
SharesIssuedForConvertibleNotesSettlement
0 usd
CY2017Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.51 pure
CY2023Q3 ahro Retained Earnings Accumulated Deficits
RetainedEarningsAccumulatedDeficits
37327746 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Specific amounts in the prior period’s financial statements have been reclassified to conform to the current presentation. These reclassifications did not affect the reported consolidated net loss.</p>
ahro Finite Lived Intangible Asset Useful Lifes
FiniteLivedIntangibleAssetUsefulLifes
P15Y
us-gaap Adjustment For Amortization
AdjustmentForAmortization
919 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
664 usd
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
600000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1053638 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1180001 usd
CY2023Q3 ahro Convertible Note Payable Discount
ConvertibleNotePayableDiscount
-94451 usd
CY2022Q4 ahro Convertible Note Payable Discount
ConvertibleNotePayableDiscount
-92000 usd
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1185693 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1243243 usd
ahro Derivative Liabilities Extinguished
DerivativeLiabilitiesExtinguished
-83994 usd
ahro Net Cash Proceeds Of Received From Related Parties For Operating Expenses
NetCashProceedsOfReceivedFromRelatedPartiesForOperatingExpenses
27913 usd
ahro Net Cash Proceeds Of Received From Related Parties For Operating Expenses
NetCashProceedsOfReceivedFromRelatedPartiesForOperatingExpenses
22939 usd
CY2023Q3 ahro Advance From Related Party Current
AdvanceFromRelatedPartyCurrent
411599 usd
CY2022Q4 ahro Advance From Related Party Current
AdvanceFromRelatedPartyCurrent
383686 usd
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
102402799 shares

Files In Submission

Name View Source Status
0001477932-23-008665-index-headers.html Edgar Link pending
0001477932-23-008665-index.html Edgar Link pending
0001477932-23-008665.txt Edgar Link pending
0001477932-23-008665-xbrl.zip Edgar Link pending
ahro-20230930.xsd Edgar Link pending
ahro-20230930_cal.xml Edgar Link unprocessable
ahro_10q.htm Edgar Link pending
ahro_ex311.htm Edgar Link pending
ahro_ex312.htm Edgar Link pending
ahro_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ahro-20230930_lab.xml Edgar Link unprocessable
ahro-20230930_pre.xml Edgar Link unprocessable
ahro-20230930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ahro_10q_htm.xml Edgar Link completed